NIH R01 · 2025
Evaluating a Novel Approach to Dispensing Methadone in Carceral Facilities
PROJECT SUMMARY Incarcerated persons have a high prevalence of opioid use disorder (OUD) and an elevated risk of nonfatal and fatal overdose following release. Methadone is a critical medication for treating OUD but is often inaccessible in carceral facilities due to the complex federal regulations that typically restrict methadone to federally licensed opioid treatment programs (OTPs). In 2024, the Substance Abuse and Mental Health Services Administration issued a final rule clarifying that any carceral facility registered with the Drug Enforcement Administration as a “hospital/clinic” is permitted to stock and dispense methadone for the treatment of OUD, as long as the patient is…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.